With the end of the year, there are all sorts of predictions about the next. But more important than predictions are specific investment ideas.
 | You're receiving this email because you are subscribed to Trading Tips,
if you no longer wish to receive these emails you can Manage Subscriptions. |  |  | |
 | | Is Boeing a Buy in 2020? | | The start of the year brings new companies into focus for investors, particularly those that had a poor showing in the prior year. There are a few different ways to classify these opportunities, but most are based on being a "dog" of some sort.
Originally, the strategy was to buy the five highest-yielding companies in the Dow Index—hence the name Dogs of the Dow. But there are variations, like using 10 names, or using the S&P 500 index, or sorting by other means.
One of those means should include companies that had operational struggles in the prior year, but could see their shares soar as those troubles go away.
When we add in that factor, Boeing (BA) looks like a great buy for 2020.
The company's problems are well-known, and seemingly aren't going away. But the company is part of a global oligopoly for airline production, and that gives it an attractive operating structure due to minimal competition.
We also know that the 737 Max problems are solvable, even if they aren't solved yet.
And we know that, despite the drop in revenues and earnings in the past year, a recovery is likely as soon as the fear dissipates.
The only question is whether Boeing can survive that long. Many companies don't have the financial firepower to deal with a major crisis without having to deal with some stark cuts.
Thanks to Boeing's low net debt, however, the company isn't so leveraged that today's problem creates an existential crisis. That makes Boeing a buy up to $350 per share—with the possibility to hit $450 or $500 as the 737 Max issues get solved.
A tiny cannabis company is about to disrupt Latin America's $31.98 billion cosmetics industry with a revolutionary new line of CBD beauty products. Then it's on to conquer CBD health care…skin care…and even the pet care markets. So far this company's flying under Wall Street's nose…
But not for long. | |
| | | YOU PROBABLY MISSED THIS: | | | | | | |
Not sure the best way to get started?
Follow these simple steps to hit the ground running. | | | › Step #1 - Get These FREE Reports: Dividend Investing Mini-Course | 10 Great Stocks Under $10 |
7 High Yield Dividend Stocks | | | | › Step #2 - Join Our Premium Advisories: The Next Superstock | Triple Digit Returns | Options Cash Cow | | | | › Step #3 - Connect With The Community: Trading Tips Official Facebook Group
| |
Nothing in this email should be considered personalized financial advice. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.
By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing The Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
As defined in the United States Securities Act of 1933 Section 27(a), as amended in the Securities Exchange Act of 1934 Section 21(e), statements in this communication which are not purely historical are forward-looking statements and include statements regarding beliefs, plans, intent, predictions or other statements of future tense.
Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.
| | | | |
No comments:
Post a Comment